GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the Fab fragment of PF06438179/GP1111 an infliximab biosimilar in a I-centered orthorhombic crystal form, lot a

Analyse Crystal structure of the Fab fragment of PF06438179/GP1111 an infliximab… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6UGT
Type
protein
Length
866 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
A8K008, Q6P5S8

Structure

x-ray diffraction · 2 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
H, A—protein220—A8K008
L, B—protein213—Q6P5S8

Ligands and binding sites

  • EDO · 1,2-ethanediol · additive · 7 copies · chains H, L, A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6UGT · Crystal structure of the Fab fragment of PF06438179/GP1111 an infliximab biosimilar in a… · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.